(Total Views: 802)
Posted On: 08/08/2020 8:14:03 PM
Post# of 154090
Re: Riztheinvestor #47963
In case there's any confusion, the EINDs should be representative of the s/c, not m2m. The positive results of m2m is no surprise due to the MOA of leronlimab on CV19.
EUA for m2m is up in the air though it shouldn't be IMO.
EUA for s/c (after interim analysis or at the end of ph3)
is a much stronger expectation due to EIND results.
CYDY will apply for m2m EUA with the topline results. This is the EUA we will be anxiously waiting for.
EUA for m2m is up in the air though it shouldn't be IMO.
EUA for s/c (after interim analysis or at the end of ph3)
is a much stronger expectation due to EIND results.
CYDY will apply for m2m EUA with the topline results. This is the EUA we will be anxiously waiting for.
(0)
(0)
